These mostly GH‐(somatotrophinomas) and/or prolactin‐secreting tumors develop in 17%–20% of AIP mutation (AIPmut) carriers, typically before 30 years of age [Beckers et al., 2013; Hernández‐Ramírez et al., 2015]. Here, AIP is linked to growth hormone-producing pituitary gland adenoma.